The Safety and Tolerability of PD-L1 Monoclonal Antibody Plus Lenalidomide in The Treatment of Colorectal Cancer
Condition(s):Colorectal NeoplasmsLast Updated:May 15, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Colorectal NeoplasmsLast Updated:May 15, 2020Unknown status
Condition(s):Peripheral T-Cell Lymphoma, Not Otherwise Specified; Angioimmunoblastic T-cell LymphomaLast Updated:April 20, 2023Recruiting
Condition(s):Rectal CancerLast Updated:July 13, 2023Recruiting
Condition(s):COVID-19Last Updated:March 7, 2022Recruiting
Condition(s):HCCLast Updated:November 15, 2019Unknown status
Condition(s):Healthy VolunteersLast Updated:March 29, 2021Completed
Condition(s):Disseminated Neuroblastoma; Recurrent Neuroblastoma; Regional NeuroblastomaLast Updated:January 16, 2013Completed
Condition(s):Colorectal CancerLast Updated:February 1, 2023Not yet recruiting
Condition(s):Multiple MyelomaLast Updated:June 15, 2016Terminated
Condition(s):Gastric and Esophagogastric Junction AdenocarcinomaLast Updated:August 24, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.